Featured Editorial & Interviews

Jun 22

Deck Bio on Solid Tumor Immunotherapy, Talent and Biotech Infrastructure

Jun 15

Noveome Biotherapeutics on Rethinking Trial Sites in Rare Neonatal Disease

Jun 08

F2G’s Global Strategy for Rare Fungal Infection Trials

Jun 01

Radiopharmaceutical Manufacturing: Ratio Therapeutics on Why Location and Logistics Matter

May 25

iBio’s Global Clinical Trial Strategy for Advancing Next-Gen Obesity Drugs

May 19

What It Takes to Run Rare Pediatric Disease Trials Across Borders: Insights from Polaryx Therapeutics